2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 26405593 | A novel targeted immunotherapy for CTCL is on its way: Anti-KIR3DL2 mAb IPH4102 is potent and safe in non-clinical studies. | 2015 Sep | 1 |
| 2 | 25361998 | IPH4102, a humanized KIR3DL2 antibody with potent activity against cutaneous T-cell lymphoma. | 2014 Nov 1 | 3 |